Microglial depletion rescues spatial memory impairment caused by LPS administration in adult mice

Area of Science:

• Neuroscience
• Immunology
• Cognitive Science

Background:

• Microglia, the brain's immune cells, play a crucial role in cognitive functions like learning and memory.
• Their precise role in both healthy and diseased states, particularly neuroinflammation, remains incompletely understood with conflicting findings.
• Understanding microglial involvement is key to addressing cognitive dysfunction in neurological diseases.

Purpose of the Study:

• To investigate the impact of adult microglial depletion on spatial learning and memory.
• To assess these effects under both normal physiological conditions and during lipopolysaccharide (LPS)-induced neuroinflammation.
• To explore the potential of targeting microglia for therapeutic interventions.

Main Methods:

• Adult mice underwent microglial depletion using the chemical agent PLX5622.
• Spatial learning and memory were assessed in both control and LPS-treated mice.
• Microglial inactivation was also studied using minocycline administration.
• Neuroinflammation markers, microglial activation, and synaptic function were analyzed post-treatment.

Main Results:

• PLX5622-mediated microglial depletion resulted in mild spatial memory impairment in healthy mice.
• However, microglial depletion significantly prevented memory deficits caused by systemic LPS administration.
• Minocycline, another microglia-inhibiting agent, replicated this protective effect against LPS-induced memory impairment.
• PLX5622 treatment effectively suppressed LPS-induced neuroinflammation, microglial activation, and synaptic dysfunction.

Conclusions:

• Microglial immunoactivation is implicated in LPS-induced synaptic and cognitive impairments.
• Targeting microglia presents a promising therapeutic strategy for neuroinflammation-associated cognitive dysfunction.
• Further research into microglial modulation could lead to treatments for neurodegenerative diseases.